Purchase Order 75N92020P00309
Award Date
9/28/20
Potential Completion Date
9/27/25
Potential Value
$600K
Funding Federal Agency
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
Contracting Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
University System Of Maryland
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to the University of Maryland, Baltimore (UMB), a major public research university, for biomedical research and services. The $510,342.33 definitive contract was awarded on December 13, 1996 by the National Institutes of Health (NIH), a civilian agency, with a period of performance through December 31, 2005. The contract has a "Cost No Fee" pricing type, and was not set aside for any special business category. UMB, the prime contractor, provides a...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to the University of Maryland, Baltimore (UMB) for data specialist services. The contract has a total ceiling value of $107,709.53 and an ultimate completion date of August 20, 2025. UMB is performing the work as the prime contractor without any set-aside designation. The contract is a continuation of an ongoing relationship between UMB and NIH, as evidenced by UMB's existing federal...
The University of Maryland, Baltimore (UMB) was awarded a $9,011,578.47 Firm Fixed Price contract by the National Institutes of Health (NIH) to provide support for the Office of AIDS Research Initiative research grant activities. This is a 5-year contract that runs through September 2027. The contract is not set aside and UMB will serve as the prime contractor. As a major academic research institution, UMB has a substantial portfolio of federal contracts and grants with agencies like NIH, the...
This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
This is a definitive contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the University of Maryland Baltimore (UMB) for $480,889.00 on a firm fixed price basis. The contract is for other management support services and does not have a set-aside designation. UMB is a state government entity and state-controlled institution of higher learning that conducts research, provides consulting, and delivers medical services to the federal...
This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for a Gastrointestinal (GI) Fellowship Program. The contract is valued at $231,760.92 and has a performance period from July 1, 2015, to June 30, 2016, with a final completion date of July 23, 2020. UMB is the prime contractor, and this award is not associated...
This is a $7,143,498.00 Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The contract, which does not have a set-aside designation, runs through September 29, 2028. Under this contract, UMB will provide a range of research, education, and clinical services to support NIAID's mission, leveraging the university's...
This is a $100,000.00 Firm Fixed Price Purchase Order contract awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract is for Biochemical Genetics Training Support for Fellows and was awarded to the University of Maryland, Baltimore (UMB) on May 1, 2024. The contract is not set aside for any specific business type. UMB is a prominent public research university...
The University of Maryland, Baltimore (UMB) has been awarded a $7,594.08 firm fixed price purchase order contract by the National Institute of Allergy and Infectious Diseases (NIAID) for micro-satellite testing and pyro-sequencing services. UMB, a major public research university, frequently receives federal contracts and grants to support its biomedical and clinical research activities. This contract, which is not set aside, is likely part of a larger research initiative at NIAID, the...